Are you ready for the new EU HTA in 2025?


On Thursday 1st December, our Managing Directors and Market Access Experts Dr Paul Craddy and Dr Graham Foxon hosted a live webinar, to discuss the latest news and updates on the EU HTA process, including the Joint Clinical Assessment and Joint Scientific Consultation processes. This new process is potentially the biggest change in the last 10+ years in EU pricing and access.

They also shared the findings from the EU HTA survey Remap published in October. You can access a PDF copy here.

To view the webinar on demand, please click below.

If you have any questions or would like to discuss the topic in more detail, please reach out.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.